News Focus
News Focus
Followers 46
Posts 13650
Boards Moderated 0
Alias Born 11/18/2016

Re: hovacre post# 55194

Monday, 02/19/2018 8:46:32 AM

Monday, February 19, 2018 8:46:32 AM

Post# of 108195
Yes, it was Chemist. What is your view, if there is approval, on the issue of market acceptance by the EU medical community, due to the limitations of the data that ADXS is using? Given the safety factor and the “last resort” nature of the treatment. And are results for other indications material to the question?

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today